Pegasys 180 ug/mL
peginterferon alfa-2a · INJECTION, SOLUTION · pharmaand GmbH
No Recall HistoryCurrently in Shortage
Plain English
Pegasys is a injection, solution containing peginterferon alfa-2a at 180 ug/mL, taken subcutaneous. Manufactured by pharmaand GmbH.
Key Facts
- Brand Name
- Pegasys
- Generic Name
- peginterferon alfa-2a
- NDC Code (Product)
82154-0449- Manufacturer
- pharmaand GmbH
- Strength
- 180 ug/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103964
- Drug Class
- Interferon alpha [EPC]
- Marketing Start
- 10/16/2002
Recall History
No Recall HistoryFrequently Asked Questions
What is Pegasys used for?
Pegasys contains peginterferon alfa-2a. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Pegasys a controlled substance?
Pegasys is not classified as a controlled substance by the DEA.
What is the generic name for Pegasys?
The generic name for Pegasys is peginterferon alfa-2a. There are no other listed brand versions of peginterferon alfa-2a.
What is the NDC code for Pegasys 180 ug/mL?
The NDC (National Drug Code) for Pegasys 180 ug/mL is 82154-0449, listed by pharmaand GmbH.
Other Pegasys Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)